Pure unit-conversion math for Tirzepatide (mg → mcg → IU on a U-100 insulin syringe). Half-life steady-state graph, cost-per-mcg comparator, shareable URL. Research use only — no clinical recommendations.
→ Open the Tirzepatide calculatorTirzepatide is a dual GLP-1 + GIP receptor agonist. Plasma half-life ~5 days, once-weekly cadence. FDA-approved as Mounjaro / Zepbound. The lean-mass-loss number landed at 19% — about half what semaglutide produces by the same methodology.
Want the deep-dive? The Compound Brief covers Tirzepatide mechanism, half-life math, and what the literature actually shows in the Sunday issue. Subscribe (free) →
Verify your vendor: See Tirzepatide COA scores at /coa-index.